---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-180184"
form_type: "8-K"
ticker: "LENZ"
cik: "0001815776"
company_name: "LENZ Therapeutics, Inc."
filed_at: "2022-06-23T23:59:59+00:00"
generated_at: "2026-06-24T23:43:16.676256+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Graphite Bio stockholders elect three Class I directors and ratify auditor at 2022 Annual Meeting

## Summary
- Stockholders elected Jerel Davis, Perry Karsen, and Joseph Jimenez as Class I directors; each received >37M votes for, ~3M withheld.
- Ratification of Deloitte & Touche as independent auditor for FY2022 passed with ~42.2M for, 5,230 against, 9,929 abstentions.
- Total shares present or represented: 42,241,989 out of 57,970,110 shares entitled to vote.
- Broker non-votes: 1,680,515 on director election; none on auditor ratification.

## SEC filing metadata
- accession: 0001193125-22-180184
- form_type: 8-K
- ticker: LENZ
- cik: 0001815776
- company_name: LENZ Therapeutics, Inc.
- filed_at: 2022-06-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815776/000119312522180184/0001193125-22-180184-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815776/000119312522180184/d350734d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-180184
- JSON: https://secwatch.observer/filing/0001193125-22-180184.json
- Plain text: https://secwatch.observer/filing/0001193125-22-180184.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.